:quality(80)/outremer%2F2025%2F05%2F14%2Fchm-mayotte-4-id13374-800x533-68246d8a6d5cc196881439.jpg "Congenital Heart Disease Awareness: Early Detection Saves Lives in Mayotte")
Congenital Heart Disease Awareness: Early Detection Saves Lives in Mayotte
- Congenital heart defects (CHDs) are the most common birth defects in the United States, affecting nearly 40,000 babies each year – that’s approximately one child every 15 minutes.
- CHDs are problems that affect the heart’s structure and function, developing during the early stages of fetal development.
- According to experts, even with advancements in treatment, a CHD is not “cured” even after repair.
Congenital heart defects (CHDs) are the most common birth defects in the United States, affecting nearly 40,000 babies each year – that’s approximately one child every 15 minutes. These structural problems with the heart are present at birth and can range in severity. Recognizing Congenital Heart Disease (CHD) Awareness Week, observed from to , highlights the critical importance of early detection, ongoing care, and continued research into these conditions.
Understanding Congenital Heart Defects
CHDs are problems that affect the heart’s structure and function, developing during the early stages of fetal development. While not always hereditary, disruptions during the formation of the heart – which begins beating as early as the third week of gestation – can lead to a variety of defects. The severity of these defects varies significantly. Some are minor and allow for normal growth and development, while others are life-threatening, requiring immediate intervention.
According to experts, even with advancements in treatment, a CHD is not “cured” even after repair. Individuals with a CHD require regular medical check-ups throughout their lives, as they are at risk for developing other health problems depending on the specific defect, its severity, and whether multiple defects are present.
Early Detection: A Lifeline for Affected Children
Early detection is paramount in improving outcomes for children born with CHDs. Screening during pregnancy, specifically a fetal echocardiogram (a specialized ultrasound), can identify some heart defects before birth. However, not all defects are detectable prenatally, meaning some may be discovered at birth or as the child grows. A neonatal complete clinical examination and neonatal pulse oximetry testing are also key components of early detection efforts.
The benefits of early diagnosis are substantial. Timely intervention, including medical management, and often surgical treatment, can significantly improve a child’s prognosis and quality of life. Advances in medical research, imaging, anesthesia, and surgical techniques have dramatically increased survival rates. Today, over 80-85% of individuals born with CHD survive into adulthood.
The Situation in Mayotte and Global Implications
In Mayotte, the need for early detection and specialized care is particularly acute. More than 120 newborns are diagnosed with a heart condition each year, and over 1,000 children are followed annually for cardiac issues. Approximately 60 children require travel off the island each year to access cardiac surgery.
The Mayotte Perinatal Network (Repema) emphasizes that quality prenatal care, including screening ultrasounds, is essential for early detection. The Service de Diagnostic Anténatal (DAN) and the pediatric cardiologists at the Mayotte General Hospital play a crucial role in this process, working in collaboration with specialized teams at the University Hospital of Réunion and national reference centers.
This situation is not unique to Mayotte. CHD is the most common congenital anomaly worldwide, affecting approximately 8–10 per 1,000 live births, or about 1 in every 100 births. This makes it a global health issue requiring global action, as highlighted by experts.
Challenges and the Importance of Support
Families affected by CHD often face significant emotional, physical, and financial challenges. The ongoing specialized care, repeated medical interventions, and potential surgical treatments can be demanding. Increased public awareness, education, compassion, and community support are vital to help these families navigate these difficulties.
Prevention also plays a role, beginning with quality antenatal care, optimizing maternal health, avoiding harmful exposures during pregnancy, and conducting early fetal assessments when indicated.
Looking Ahead
While CHD is a lifelong condition, it is treatable. Continued research is essential to improve diagnostic tools, refine surgical techniques, and find cures. Raising awareness, promoting early detection, and ensuring access to specialized care are crucial steps in improving the lives of individuals living with CHD and their families. Informing and sensitizing both parents and healthcare professionals allows for earlier diagnosis, rapid care, and saves lives.